throbber
Eye Therapies Exhibit 2045, 1 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 2 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 3 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Big Is Back
`
`Achieving top-10 New Product Pacesetter status
`takes a robust year, and always has. But products
`in 2019 had to work a little harder to achieve this
`status. In food and beverage this is especially
`poignant — No. 10 Pop-Tarts Bites generated more
`than $68 million in multi-outlet sales compared with
`the $50 million milestone of years past. In non-food,
`it is primarily the top four that show the fight to
`hold top spots. No. 4 Harry’s generated nearly $170
`million, compared with No. 4 from 2018’s ranking
`when Tide Pods Plus Downy brought in $82 million.
`
`Historically there had been a decline in the dollar
`threshold, until 2019, which reported a rebound.
`One outlet that played a considerable role in this
`movement was convenience stores, as they are
`home to niche innovations that capture broad
`appeal. The No. 1 c-store product Juul, for example,
`generated $2.4 billion in sales. Electronic smoking
`devices boomed as consumers often perceived
`them as healthier or less conspicuous than cigarettes
`and found the flavors and options alluring.
`
`$100M+
`10 products in multi-outlet
`channels achieved sales
`of $100M+, along with eight
`products in the convenience
`channel, marking the return
`of blockbuster New
`Product Pacesetters.
`
`The Squeeze Continues for Medium-sized Companies Caught
`Amid Innovation from Big and Small Companies
`
`% of Total Count
`
`% of Total Dollars
`
`23%
`
`46%
`
`38%
`
`37%
`
`29%
`
`35%
`
`38%
`
`44%
`
`12%
`
`15%
`
`14%
`
`34%
`
`28%
`
`37%
`
`23%
`
`30%
`
`35%
`
`31%
`
`30%
`
`23%
`
`31%
`
`28%
`
`26%
`
`26%
`
`19%
`
`20%
`
`19%
`
`24%
`
`14%
`
`12%
`
`13%
`
`10%
`
`26%
`
`26%
`
`41%
`
`34%
`
`4%
`
`11%
`
`8%
`
`8%
`
`7%
`
`16%
`
`19%
`
`19%
`
`49%
`
`30%
`
`27%
`
`22%
`
`62%
`
`60%
`
`52%
`
`49%
`
`86%
`
`43%
`
`46$
`
`52%
`
`2012
`
`2013
`
`2104
`
`2015
`
`2016
`
`2017
`
`2018
`
`2019
`
`2012
`
`2013
`
`2104
`
`2015
`
`2016
`
`2017
`
`2018
`
`2019
`
`Big Companies
`>$5.5B
`
`
`
`Medium Companies
`$1B – $5.5B
`
`
`
`Small Companies
`$100M – <$1B
`
`
`
`Extra-Small Companies
`<$100M
`
`
`
`Source: 2019 New Product Pacesetters
`
`NEW PRODUCT PACESETTERS: Innovation Before the “New Normal”
`
`IRIworldwide.com
`
`4
`
`SPECIAL REPORT
`
`Eye Therapies Exhibit 2045, 4 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Eye Therapies Exhibit 2045, 5 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`The Road from Specialty to Mass Market
`
`Niche brands have
`great appeal, and in
`many segments and
`markets they are stars.
`Sometimes a niche
`brand can maintain that
`unique, targeted appeal
`while transforming to a
`mass-market brand. Harry’s razors, for one, tells the
`tale of a once-direct-to-consumer product filling a
`unique need — high-end razor performance and
`feel at an affordable price. With the shift to retail,
`the brand racked up almost $170 million in sales and
`finds itself at major retail locations, including Target,
`Walmart and Kroger, albeit typically merchandised
`as a specialty section within the men’s personal-care
`real estate. These numbers are exclusive of any other
`channels, including e-commerce, perhaps propelling
`brand sales even more significantly when you look
`at its “all-in” numbers.
`
`By having powerful retail distribution — not in every
`store, but in the right stores — Harry’s got it right
`with the look and feel of niche marketing with
`mass-market exposure. Harry’s carries with it the
`mentality of direct-to-consumer products with sharp
`aesthetics and a strong back-story with blades made
`in a century-old European factory bought by two
`entrepreneurs with start-up passion and drive. The
`brand looks and feels exclusive, while it’s accessible
`to the masses and drumming up significant sales.
`
`Following the successful
`disruption of the razor market
`in the men’s space, Harry’s
`pushed into women’s razors
`with the brand Flamingo. The
`idea took hold as personal
`care makes strong connections
`with women, and in just a few years, the brand has
`extended into skincare with products beyond shaving
`to include waxing and skin lotions and treatments.
`Target stores feature Flamingo brand products.
`
`Similarly, Bubly grabs the
`No. 4 Food & Beverage
`position with $116.3
`million in multi-outlet
`sales. It also characterizes
`the feels-small, performs-
`big role in the crowded
`carbonated-soft-drink and carbonated-water market.
`Owned by PepsiCo, Bubly exemplifies a small brand
`with a big image from a big company, thanks to its
`attributes and attractive packaging, as well as its
`deep-pocket marketing and merchandising. It carries
`the aura of a small, niche brand, but the power of
`a big-brand player to help it find and connect with
`consumers who appreciate unique brands.
`
`$19M
`
`Median sales of a
`2019 Food & Beverage
`Pacesetter are $19M,
`up from $11M in 2018
`
`NEW PRODUCT PACESETTERS: Innovation Before the “New Normal”
`
`IRIworldwide.com
`
`6
`
`SPECIAL REPORT
`
`Eye Therapies Exhibit 2045, 6 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Big companies have made a big splash this year with
`24% of New Product Pacesetter products and half
`the Pacesetter dollars coming from big companies.
`However, a look at the total New Product Pacesetters
`list tells another interesting story.
`
`In recent years, trends indicate that 40-50% of New
`Product Pacesetters come from combined small and
`extra-small companies, defined by $1 billion in sales
`or less. Small companies bring innovation, they bring
`successful products, and they bring the flexibility to
`act fast. Often, they’re less hindered by stage-gate
`processes incumbent in larger businesses, and often
`there are private investors supporting the process
`and thus allowing for more risk, and thus more reward.
`
`In 2019, small companies represented 53% of
`New Product Pacesetters, taking on the challenge
`to achieve wide enough distribution to generate
`impressive sales. The “Shark Tank” effect is at
`play here, with small, driven, inspired companies
`breaking through with grit and determination to
`get products noticed and distributed both in the
`marketplace and with the Sharks on the TV program.
`There’s a distinct mentality here, and the product
`must effectively tap and deliver on a niche need
`that is broadly recognized. Particular ingredients,
`including non-animal protein sources, or value-added
`benefits such as proteins and vitamins, or functions
`such as convenience in personal care, can generate
`excitement and connect with a broad, yet targeted
`swath of consumers. Playing on niche innovation can
`translate to large dollars when an attribute is unique
`yet still offers generally sought-after benefits.
`
`Products experiencing the
`Shark Tank effect are solid,
`but unique, and once they
`get an endorsement from
`the show and the Sharks,
`they gain the distribution
`needed for true traction and organic growth.
`Often these product successes encompass a twist on
`something established. Kodiak Cakes Power Waffles
`infuse excitement in a long-established category
`with a boost of the sought-after attribute of protein.
`Protein-seeking emerges as a trend given that 38 of
`the top 100 and three of top 10 food and beverage
`Pacesetters offer protein benefits.
`
`Chickpea-based Banza
`noodles also focus on the
`lack of carbs and benefit
`of protein. In four* years,
`Banza has become Whole
`Foods’ best-selling pasta
`and Target's second-
`best-selling pasta. Banza
`exemplifies a product
`creating a groundswell at specialty markets,
`expanding its reach and gaining positioning into
`mass markets, achieving the distribution level to earn
`Pacesetter status. Products such as these illustrate
`how a few years of success in specialty markets can
`be the spark needed to sway bigger retailer adoption,
`and spur distribution needed for winning positions.
`
`Dude Wipes is a
`product banking
`on the success of
`the wipe format in
`baby, household and
`auto by specifically
`delivering a personal care product for men, and
`especially adolescent boys. Making its first Shark
`Tank appearance — and deal with Shark Mark Cuban
`— in 2015, distribution expanded regionally in Target
`stores. Then, after a second Shark Tank appearance,
`the brand’s distribution spanned the country, putting
`it in a position to earn Pacesetter status.
`
`Consumer groups vary, and the market is complex,
`but products that win with consumers tap into an
`intentional look, feel, performance, experience or
`any and all combination of those features. While
`big-budget brands often have an edge, consumers
`typically don’t care if a company is big or small; the
`brand story and image — and how it fits into their
`own lives — matters more.
`
`
`
`
`Three 2019 New
`Product Pacesetters
`boast the “Shark
`Tank” effect, gaining the
`support needed to thrive
`in a broad marketplace.
`
`*Please refer to the New Product Pacesetter criteria on page 22.
`
`NEW PRODUCT PACESETTERS: Innovation Before the “New Normal”
`
`IRIworldwide.com
`
`7
`
`SPECIAL REPORT
`
`Eye Therapies Exhibit 2045, 7 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Eye Therapies Exhibit 2045, 8 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Eye Therapies Exhibit 2045, 9 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Eye Therapies Exhibit 2045, 10 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 11 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 12 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Schmidt’s
`
`
`
`
`
`
`
`
`
`The mass distribution bolstered Schmidt’s to
`reach more than $26 million in sales and a
`position on the New Product Pacesetters rankings.
`The evolution of the Schmidt’s brand has taken its
`reputation as a high-performing, natural deodorant
`product and embraced it across more categories
`— the company pivoted to expand into homecare
`with natural cleaning products, as well as personal
`care products, including toothpaste for kids. The
`brand carries a great story, which many consumers
`today value. It feels like a purchase that is good
`for one’s family — a healthy choice, which today
`carries a lot of weight, especially for young families
`with income levels that allow for taking risks and
`exploring products and various price points.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Schmidt’s brand
`deodorant was born
`in a Portland, Oregon,
`kitchen only a decade
`ago, touting its natural
`composition and
`effectiveness. Just five
`years later, the company grew and expanded
`into retail channels, and then just a few years
`after that came the boom that shot Schmidt’s to
`the big leagues. In 2018 Unilever acquired the
`brand, which by then had grown to feature natural
`beauty and personal care products and expanded
`distribution. The brand delivered Unilever an
`opportunity to reach a new, natural-focused
`audience, and make a niche, natural product
`available to a mass-market audience.
`
`Strategy Success Stories
`
`Enfamil NeuroPro
`No. 2 on the Food & Beverage
`Pacesetter rankings, Enfamil
`NeuroPro formula generated
`more than $230 million in
`multi-outlet sales. This special
`formula that imitates mother’s
`milk takes the baby formula
`category to a new place scientifically. The product
`features MFGM (Milk Fat Globule Membrane),
`which is found in breast milk and supports cognitive
`development in brain structure and function. Enfamil
`NeuroPro taps into a huge market of parents who
`value the nutritional support of breast milk but, for
`any number of reasons, choose formula.
`
`The success of Enfamil NeuroPro can be attributed
`to a few key factors, including parents’ willingness
`to buy the best for their children and the busy
`life new moms lead that may inhibit breast
`feeding even when they desire the benefits. But
`most notably, this is a revolutionary step in the
`nutritional composition of baby formula — the
`first major scientific enhancement since DHA
`fortification became FDA approved more than
`two decades ago.
`
`Leveraging its reputation as a high-performing natural
`deodorant brand, Schmidt's has expanded into other
`personal care and even homecare categories — all while
`still focused on natural wellness.
`
`NEW PRODUCT PACESETTERS: Innovation Before the “New Normal”
`
`IRIworldwide.com
`
`13
`
`SPECIAL REPORT
`
`Eye Therapies Exhibit 2045, 13 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Consumers Gravitate to Natural, Healthy
`
`New Product Pacesetter performance in 2019
`represented consumer behavior in a pre-COVID-19
`world. The next New Product Pacesetters chapter
`will be one where the retail marketplace and
`consumer groups will have evolved and behaviors
`undoubtedly will be different. How different is the
`big question.
`
`Both Enfamil NeuroPro and Schmidt’s reflect a
`relevant and likely lasting trend shown across New
`Product Pacesetters both in food and beverage
`and in non-food categories: natural/pure/non-
`GMO ingredients matter to consumers today.
`Three of the top 10 and 25 of the top 100 Food &
`Beverage Pacesetters offer non-GMO benefits, with
`
`products including SlimFast
`Keto offering low-carb,
`ketogenic nutrition; PERDUE
`SIMPLY SMART Organics,
`featuring organic meats and
`non-GMO ingredients; and
`Arnold, Brownberry and
`Oroweat Sandwich Thins, relaunched with premium
`ingredients and a dose of fiber in a low-calorie
`bread product.
`
`Two of the top 10 and 25 of the top 100 in non-
`food tout natural/simple ingredients, with products
`including Johnson's CottonTouch bath products,
`made with real cotton, pH balance for a newborn
`
`and no parabens, phthalates
`or sulfates; Downy Nature
`Blends, a plant-based fabric
`conditioner made with a touch
`of coconut oil, and without
`dyes or parabens; Blue Buffalo
`pet food made with high-quality ingredients; and
`Pampers Pure Collection of diapers and wipes,
`made with premium cotton and other plant-based
`ingredients.
`
`Products considered healthier for bodies and for
`the environment continue to capture consumer
`interest, even if they carry higher price points
`thanks to the perceived or actual value. Homecare
`products could potentially tell an interesting
`tale in the post-COVID-19 world given people’s
`new diligence for killing germs and protecting
`themselves and their families. Will consumers
`continue to value natural and pure in this space?
`Overall, people’s health and wellness efforts won’t
`waver — and may boom — in order to stay healthy
`and build immunity, so watching consumer trends
`in this space is imperative.
`
`NEW PRODUCT PACESETTERS: Innovation Before the “New Normal”
`
`IRIworldwide.com
`
`14
`
`SPECIAL REPORT
`
`Eye Therapies Exhibit 2045, 14 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`This year’s New Products
`Rising Stars will continue
`to tell a meaningful story,
`but the plot arc is still to be
`determined. In Non-Food
`Rising Stars, a number of
`products tout natural and
`simple ingredients, mirroring
`trends in Pacesetters. For example, Rising Star
`Greenies pet dental treats echo similar messaging
`and the growth pattern set by 2018’s pet Pacesetter
`Nature's Recipe and this year’s Blue Buffalo.
`Personal care deodorant brand Native took the
`leap from online to multi-outlet sales in 2019,
`much like this year’s Schmidt’s, indicating a strong
`predilection for landing on the Pacesetters list next
`year as people embrace natural products.
`
`In Food & Beverage Rising Stars, three energy
`drinks lead the way and join two ice creams. The
`presence of ice cream shows people still indulge
`and treat themselves, even though a large portion
`of the population remains focused on health and
`wellness. And energy drinks show that people still
`fight to cram everything into a day and are looking
`for a boost. Though the parallels of Rising Stars
`in food and beverage are not as present in this
`year’s top winners, Bang Energy did just that and
`made a huge bang. Other indulgent products
`such as Pop-Tarts Bites and Enlightened Ice Cream
`grabbed 2019 Rising Stars spots and could pave
`the way to Pacesetter status.
`
`Dollar sales trends in Rising Stars and Pacesetters
`often lead the story, but indicators show that 2019
`could be an aberration in year-one revenue and
`that good innovation launches are not just tied to
`dollars. Innovation meets consumer-demonstrated
`needs and large dollars are not always needed
`to satiate an unmet need. While Pacesetters saw
`record numbers of $100 million-plus launches,
`Rising Stars still signal success for launches
`large and small. We expect a decline in year-
`one revenue, and that was before the advent of
`COVID-19, another potential hurdle or opportunity
`for manufacturers.
`
`Historically Rising Stars make the leap to Pacesetter
`status, but in our new normal, will they continue to
`be important to manufacturers fighting to keep the
`supply chain full with the types of products people
`know they want and need?
`
`Or will Rising Stars get the win as people find ways
`to treat and indulge in otherwise very trying times.
`Already ice creams and frozen novelties are a
`trend noted in this year’s New Product Pacesetters,
`especially kids’ and less calorie versions, which
`may reflect an interest in indulgence in moderation.
`There are eight ice cream and novelty products in
`the top 100 Food & Beverage Pacesetters.
`
`We forecast that product-launch timetables will
`play a more significant role in the coming years
`because of long-term effects from changed
`COVID-19 behaviors. This year, more than half
`of non-food Pacesetters and about one-third of
`food and beverage Pacesetters achieved 30%
`distribution or more in the first quarter of the
`calendar year. This timing holds year after year,
`represented across products earning Pacesetter
`status. Thus, it’s likely that the lion’s share of
`innovation for this year is already on the market,
`facing a never-anticipated COVID-19 environment.
`
`Rising Stars of next year launched this year
`amid the COVID-19 chaos and, given historical
`trends, launched in first quarter. Manufacturers
`and brand owners need to closely monitor the
`ability to source ingredients and production and
`distribution in a taxing supply chain. They will likely
`face headwind in new product development and
`consumer adoption.
`
`More than half of 2019
`Non-Food Pacesetters and
`one-third of Food & Beverage
`Pacesetters achieved 30%
`distribution or more in the first
`quarter of the calendar year.
`
`NEW PRODUCT PACESETTERS: Innovation Before the “New Normal”
`
`IRIworldwide.com
`
`15
`
`SPECIAL REPORT
`
`Eye Therapies Exhibit 2045, 15 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Eye Therapies Exhibit 2045, 16 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 17 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 18 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 19 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 20 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 21 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`ABOUT NEW PRODUCT PACESETTERS
`IRI has a long history of celebrating the consumer
`packaged goods (CPG) industry’s most powerful
`brand launches. New Product Pacesetters is
`consistently rich with iconic brands and game-
`changing innovations, brought to market by
`behemoths and new market entrants. New Product
`Pacesetters gives innovators inside and outside
`the CPG industry an opportunity to learn from the
`best of the best in new product innovation and
`learn the strategies for accelerating growth.
`
`ABOUT THE AUTHORS
`Joan Driggs is the vice president of Content and
`Thought Leadership in the Chicago office of IRI.
`You may email her at
`Joan.Driggs@IRIworldwide.com.
`
`Larry Levin is the executive vice president of
`Consumer & Shopper Marketing, Sales and
`Thought Leadership in the Chicago office of IRI.
`You may email him at
`Larry.Levin@IRIworldwide.com.
`
`ACKNOWLEDGMENTS
`Vital and appreciated contributors to the
`development and analysis of this report include
`Claudia Burgos and Ryan Stredney, new product
`specialists in the Chicago office of IRI.
`
`IRI NEW PRODUCT PACESETTER CRITERIA
`• Completed a full year of sales in calendar-year
`2019 (brands that complete year one in 2020
`qualify for Rising Star status, the top 10 brands
`based on a projected year-one sales total, that
`would have crossed 30% ACV in the February
`2019 quad or later).
`
`• Begin tracking year-one sales after 30% ACV
`weighted distribution achieved across multi-
`outlet geography; must have 30% ACV or
`higher at date of year-one completion.
`
`• New Product Pacesetters are the Top 100 new
`banners (for each, food and beverage, and
`non-food) based on year-one sales across
`multi-outlet geography.
`
`• MULO/multi-outlet = supermarkets, drugstores,
`mass market retailers, military commissaries,
`and select club and dollar retail chains.
`
`NEW PRODUCT PACESETTERS: Innovation Before the “New Normal”
`
`IRIworldwide.com
`
`22
`
`SPECIAL REPORT
`
`Eye Therapies Exhibit 2045, 22 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Eye Therapies Exhibit 2045, 23 of 23
`Slayback v. Eye Therapies - IPR2022-00142
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket